Epalrestat
Epalrestat CAS br.: 82159-09-9 Epalrestat
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat se koristi za prevenciju, poboljšanje i liječenje periferne neuropatije (utrnulost, bol), vibracijske parestezije i srčane abnormalnosti povezane s dijabetesom. SPECIFIKACIJA
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat se koristi za prevenciju, poboljšanje i liječenje periferne neuropatije (utrnulost, bol), vibracijske parestezije i srčane abnormalnosti povezane s dijabetesom. SPECIFIKACIJA
P ime roduct | Epalrestat |
CAS | 82159-09-9 Epalrestat |
MF: | C15H13NO3S2 |
MW: | 319,4 |
Ovdje napišite svoju poruku i pošaljite nam je